Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radical prostatectomy or deferred treatment?

U E Studer1

  • 1Department of Urology, University of Berne, Switzerland.

Seminars in Surgical Oncology
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zero fluid balance and normotension prevents complications, not the amount of fluid per se.

World journal of urology·2018
Same author

[In Process Citation].

Aktuelle Urologie·2015
Same author

Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Indications for continent diversion after cystectomy and factors affecting long-term results.

Urologic oncology·2011
Same author

The role of exenterative surgery and urinary diversion in persistent or locally recurrent gynecological malignancy: complications and survival.

Urologia internationalis·2010
Same author

[Studer ileum neobladder].

Aktuelle Urologie·2010
Same journal

Preoperative chemoradiation for locally advanced rectal cancer: rationale, technique, and results of treatment.

Seminars in surgical oncology·2003
Same journal

Preoperative chemoradiation for locally advanced rectal adenocarcinoma-the University of Florida experience.

Seminars in surgical oncology·2003
Same journal

Postoperative adjuvant therapy for pancreatic cancer.

Seminars in surgical oncology·2003
Same journal

Conformal chemoradiation for primary and metastatic liver malignancies.

Seminars in surgical oncology·2003
Same journal

Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.

Seminars in surgical oncology·2003
Same journal

Combined modality therapy in esophageal cancer: the Memorial experience.

Seminars in surgical oncology·2003
See all related articles

Increased prostate cancer screening leads to more diagnoses but stable death rates, suggesting many cases may not be fatal. This highlights the risk of overtreatment versus the benefits of radical prostatectomy.

Area of Science:

  • Urology
  • Oncology
  • Medical Diagnostics

Background:

  • Prostate cancer screening has increased due to greater awareness and advanced diagnostic tools like prostate-specific antigen (PSA) tests.
  • This has led to a rapid rise in newly diagnosed prostate cancer cases.
  • However, prostate cancer mortality rates remain largely stable.

Purpose of the Study:

  • To evaluate the implications of increased prostate cancer diagnoses on treatment strategies.
  • To address the risk of overtreatment for potentially non-fatal prostate cancers.
  • To determine the optimal management approach for organ-confined prostate cancer in younger patients.

Main Methods:

  • Analysis of trends in prostate cancer diagnosis, mortality, and treatment outcomes.

Related Experiment Videos

  • Review of the benefits and risks associated with radical prostatectomy.
  • Consideration of the limitations of current diagnostic tools in predicting disease lethality.

    • Main Results:

    • A growing number of prostate cancer diagnoses do not correspond to an increase in deaths, indicating a rise in non-fatal cases.
    • Long-term survival after radical prostatectomy may be attributed to the disease's inherent biological potential rather than solely to treatment.
    • Radical prostatectomy carries costs, morbidity, and low mortality risks that must be balanced against potential overtreatment.

    Conclusions:

    • Not all diagnosed prostate cancers necessitate radical treatment.
    • The decision for radical prostatectomy must weigh overtreatment risks against survival benefits.
    • Radical prostatectomy remains the recommended treatment for younger patients with organ-confined disease due to limitations in predicting fatal outcomes.